What is daraxonrasib?

Daraxonrasib is a new kind of Ras inhibitor called a Ras(On) multi-selective inhibitor, which works by targeting the Kras protein that fuels nearly all pancreatic cancers.

How does daraxonrasib work?

Daraxonrasib works by gluing molecules together to grab and shut down the Kras protein, which can turn off cancer growth whether there is a Kras variant or not.

What are the benefits of daraxonrasib?

The benefits of daraxonrasib include the potential to double survival time in patients with advanced pancreatic cancer, with an average of 13.2 months compared to 6.6-6.7 months for chemotherapy.

What are the side effects of daraxonrasib?

The clinical trial showed that daraxonrasib had fewer side-effects compared to chemotherapy, but it's essential to talk to your doctor about the potential benefits and risks of the drug.

Is daraxonrasib available to patients?

The next step will be ensuring that daraxonrasib is made available to patients, with experts calling for action to make promising new treatments accessible.

What is daraxonrasib?

Daraxonrasib is a new kind of Ras inhibitor called a Ras(On) multi-selective inhibitor, which works by targeting the Kras protein that fuels nearly all pancreatic cancers.

How does daraxonrasib work?

Daraxonrasib works by gluing molecules together to grab and shut down the Kras protein, which can turn off cancer growth whether there is a Kras variant or not.

What are the benefits of daraxonrasib?

The benefits of daraxonrasib include the potential to double survival time in patients with advanced pancreatic cancer, with an average of 13.2 months compared to 6.6-6.7 months for chemotherapy.

What are the side effects of daraxonrasib?

The clinical trial showed that daraxonrasib had fewer side-effects compared to chemotherapy, but it's essential to talk to your doctor about the potential benefits and risks of the drug.

Is daraxonrasib available to patients?

The next step will be ensuring that daraxonrasib is made available to patients, with experts calling for action to make promising new treatments accessible.

Back to Trending News

Published: RecentDownload AppJoin Telegram

Daraxonrasib Is a Gamechanger for Pancreatic Cancer — Here's What's Really Going On

#pancreatic cancer#daraxonrasib#cancer treatment#clinical trial#Ras inhibitor#global

Download App Join Community

Sudden Cardiac Death in Young Women: A Hidden Threat

1 Jun 2026Read Article